Filters
Patients who recovered from COVID-19 harbour SARS-CoV-2-specific T cells as shown in a Singapore study. This, the scientists suggest, bodes well for the development of long-term protective immunity against the coronavirus.
Deep vein thrombosis (DVT) appears to be common in patients with the coronavirus disease 2019 (COVID-19) and is associated with worse outcomes, a new study has found.
The survival benefits associated with treating hepatitis C virus (HCV) infections are driven primarily by a reduction in liver-related mortality, a recent study has found.
Among patients with COVID-19, acute myocardial injury occurs commonly, especially in the elderly with pre-existing cardiovascular disease, and is tied to poor prognosis, a study has found.
Among COVID-19 patients without severe chronic liver disease, liver abnormalities seen during infection are usually mild and tend to resolve over time, as reported in a study. These alterations are tied to increased risk of ICU admission but not death.
Exposure to coronaviruses appears to trigger a stable and multispecific T cell immune response to the structural nucleocapsid protein (NP), according to a recent study.
Oral antithrombotic therapies do not seem to confer survival benefits in nursing home residents with the coronavirus disease 2019 (COVID-19), a new study has shown.
Convalescent plasma therapy does not appear to improve clinical outcomes or mortality in patients with severe or life-threatening COVID-19, according to a study from China.
Use of intravenous antibiotics is sufficient to treat children with ventriculoperitoneal (VP) shunt infections, particularly those infected by Gram-negative organisms and with cerebrospinal fluid (CSF) glucose level of >40 mg/dl, suggests an Iran study.
Treatment with statins among individuals with type 2 diabetes, cardiovascular disease (CVD), or hypertension who are also positive for the novel coronavirus disease (COVID-19) must not be stopped unless there are specific contraindications, according to a study.
